Treatment of an Inherited Ventricular Arrhythmia

NCT05122975 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Due to challenges in recruiting patients.

Conditions

Catecholaminergic Polymorphic Ventricular Tachycardia Type 1

Interventions

DRUG: S48168 (ARM210)
DRUG: Matching Placebo

Sponsor

RyCarma Therapeutics, Inc.